Over the past few years, GLP-1 medications have transformed from treatments primarily prescribed for Type 2 diabetes into one of the most talked-about employee benefits in the workplace. Drugs such as semaglutide and tirzepatide have demonstrated significant success...
Return-to-office mandates are back in the spotlight, and employers are once again asking a familiar question: where does work happen best? For some organizations, the answer is simple: bring people back. Leaders point to collaboration, mentoring, culture,...
Healthcare costs have been climbing for years, but 2027 is shaping up to present one of the biggest challenges employers have faced in nearly two decades. Industry analysts are projecting employer-sponsored healthcare costs to increase approximately 9% in 2027—the...